Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00821132 · ClinicalTrials.gov registry record
Genetics of Familial and Sporadic ALS
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 13,521
- Enrollment target
NCT00821132: Completed study, sponsored by Northwestern University.
NCT00821132 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 13,521 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00821132 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 13,521 participants
- Enrollment target
Study Summary
We are collecting blood samples, clinical and family information from ALS (amyotrophic lateral sclerosis) patients and their families to identify causes of ALS and ALS/dementia.
Primary Outcome
Study of each identified gene will help us understand the molecular events that produce different types of ALS. This will aid in identification of markers that may be associated with each type which will assist with diagnosis and may provide targets for rational therapy.
Interventions
- OTHER Genetic study of ALS families
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,521 participants |
| Start Date | 1991-01 |
| Est. Completion | 2023-01 |
What the finished NCT00821132 record still lists
NCT00821132 is an observational study that tracks outcomes without assigning an intervention. Its 13,521 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Genetic study of ALS families is the first listed.
NCT00821132 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00821132 about?
NCT00821132 is a clinical study titled "Genetics of Familial and Sporadic ALS". We are collecting blood samples, clinical and family information from ALS (amyotrophic lateral sclerosis) patients and their families to identify causes of ALS and ALS/dementia.
What is the current status of trial NCT00821132?
This trial is currently completed. The enrollment target is 13,521 participants. The study started on 1991-01. Estimated completion is 2023-01.
What interventions are being tested in trial NCT00821132?
The interventions under investigation include: Genetic study of ALS families (OTHER).
Who is sponsoring clinical trial NCT00821132?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia